SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
GLASSMAN DANIEL

(Last) (First) (Middle)
383 ROUTE 46 WEST

(Street)
FAIRFIELD NJ 07004

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRADLEY PHARMACEUTICALS INC [ BDY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chairman, Pres. & CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2004
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/08/2004 I 31,279 A $8.81 299,090 D
Common Stock 8,460 I By DLD Partners
Common Stock 11,500 I By IRA
Common Stock 13,880 I With Spouse
Common Stock 10,921 I By 401K
Common Stock 3,030 I By 401K Match
Common Stock 14,000 I By The Five G's Foundation
Class B Common Stock 309,361 D
Class B Common Stock 16,005 I By Banyan Communications Group, Inc.
Class B Common Stock 57,370 I With Spouse
Class B Common Stock 9,733 I By 5G's Partnership
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to buy) $1.1687 10/26/2002 10/25/2004 Common Stock 150,000 150,000 D
Stock Options (Right to buy) $1.4093 09/12/2003 09/11/2005 Common Stock 18,000 18,000 D
Stock Options (Right to buy) $1.4437 12/05/2000 12/04/2005 Common Stock 341,589 341,589 D
Stock Options (Right to buy) $2.1656 02/23/2001 02/22/2006 Common Stock 25,000 25,000 D
Stock Options (Right to buy) $8.81 07/08/2004 I 31,279 07/09/2003 07/08/2004 Common Stock 31,279 $8.81 0 D
Stock Options (Right to buy) $10.58 07/09/2003 07/08/2006 Common Stock 12,554 12,554 D
Stock Options (Right to buy) $13.126 03/22/2005 03/21/2007 Common Stock 315,000 315,000 D
Explanation of Responses:
Daniel Glassman 07/09/2004
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.